Clinical Trial Update: Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections [Phase 3]

View source ↗

Summary

Phase 3 comparative trial evaluating Telithromycin once daily versus Cefuroxime axetil twice daily in children with otitis media; the study status is terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Cefuroxime axetil (cefuroxime axetil)
• Telithromycin (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Otitis Media | Phase 3 | Status: TERMINATED